Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker

Neurobiology of Aging

Volumn 34, Issue 3, 2013, Pages 757-769

  Ando, Kunie ^a,b   Dourlen, Pierre ^a,b   Sambo, Anne Véronique ^a,b   Bretteville, Alexis ^a,b   Bélarbi, Karim ^a,b   Vingtdeux, Valérie ^a,b   Eddarkaoui, Sabiha ^a,b   Drobecq, Hervé ^b,c   Ghestem, Antoine ^a,b   Bégard, Séverine ^a,b   Demey Thomas, Emmanuelle ^d   Melnyk, Patricia ^b,c   Smet, Caroline ^e   Lippens, Guy ^e   Maurage, Claude Alain ^a,b,f   Caillet Boudin, Marie Laure ^a,b   Verdier, Yann ^d   Vinh, Joelle ^d   Landrieu, Isabelle ^e   Galas, Marie Christine ^a,b   Blum, David ^a,b   Hamdane, Malika ^a,b   Sergeant, Nicolas ^a,b,f   Buée, Luc ^a,b,f   more..

^a INSERM   (France)

^b UNIV LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acetylation; Alzheimer's disease; Biomarker; Microtubule associated protein tau; Phosphorylation; Pin1; Posttranslational modification; Proteomics; Tauopathy

Indexed keywords

PEPTIDYLPROLYL ISOMERASE PIN1;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MOUSE; NITROSYLATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; TAUOPATHY;

ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; OXIDATION-REDUCTION; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROLINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; SERINE; TAU PROTEINS; TAUOPATHIES;

EID: 84870499729     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.08.004     Document Type: Article

References (41)

1. Augustinack J.C., Schneider A., Mandelkow E.M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002, 103:26-35.
2. Belarbi K., Schindowski K., Burnouf S., Caillierez R., Grosjean M.E., Demeyer D., Hamdane M., Sergeant N., Blum D., Buée L. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Curr. Alzheimer Res 2009, 6:152-157.
3. Bretteville A., Ando K., Ghestem A., Loyens A., Bégard S., Beauvillain J.C., Sergeant N., Hamdane M., Buée L. Two-dimensional electrophoresis of Tau mutants reveals specific phosphorylation pattern likely linked to early Tau conformational changes. PLoS One 2009, 4:e4843.
4. Bussière T., Hof P.R., Mailliot C., Brown C.D., Caillet-Boudin M.L., Perl D.P., Buée L., Delacourte A. Phosphorylated serine422 on Tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol 1999, 97:221-230.
5. Butterfield D.A., Poon H.F., St Clair D., Keller J.N., Pierce W.M., Klein J.B., Markesbery W.R. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis 2006, 22:223-232.
6. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
7. Dakson A., Yokota O., Esiri M., Bigio E.H., Horan M., Pendleton N., Richardson A., Neary D., Snowden J.S., Robinson A., Davidson Y.S., Mann D.M. Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology. Acta Neuropathol 2011, 121:635-649.
8. Delacourte A., Sergeant N., Champain D., Wattez A., Maurage C.A., Lebert F., Pasquier F., David J.P. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology 2002, 59:398-407.
9. Eckerdt F., Yuan J., Saxena K., Martin B., Kappel S., Lindenau C., Kramer A., Naumann S., Daum S., Fischer G., Dikic I., Kaufmann M., Strebhardt K. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem 2005, 280:36575-36583.
10. Fanghänel J., Akiyama H., Uchida C., Uchida T. Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/- mice. FEBS Lett. 2006, 580:3237-3245.
11. Galas M.C., Dourlen P., Bégard S., Ando K., Blum D., Hamdane M., Buée L. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J. Biol. Chem 2006, 281:19296-19304.
12. Hamdane M., Dourlen P., Bretteville A., Sambo A.V., Ferreira S., Ando K., Kerdraon O., Bégard S., Geay L., Lippens G., Sergeant N., Delacourte A., Maurage C.A., Galas M.C., Buée L. Pin1 allows for differential Tau dephosphorylation in neuronal cells. Mol. Cell. Neurosci 2006, 32:155-160.
13. Hamdane M., Smet C., Sambo A.V., Leroy A., Wieruszeski J.M., Delobel P., Maurage C.A., Ghestem A., Wintjens R., Bégard S., Sergeant N., Delacourte A., Horvath D., Landrieu I., Lippens G., Buée L. Pin1: a therapeutic target in Alzheimer neurodegeneration. J. Mol. Neurosci 2002, 19:275-287.
14. Holzer M., Gärtner U., Stöbe A., Härtig W., Gruschka H., Brückner M.K., Arendt T. Inverse association of Pin1 and Tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol 2002, 104:471-481.
15. Landrieu I., Smet C., Wieruszeski J.M., Sambo A.V., Wintjens R., Buée L., Lippens G. Exploring the molecular function of PIN1 by nuclear magnetic resonance. Curr. Protein Pept. Sci 2006, 7:179-194.
16. Lee T.H., Chen C.H., Suizu F., Huang P., Schiene-Fischer C., Daum S., Zhang Y.J., Goate A., Chen R.H., Zhou X.Z., Lu K.P. Death-associated protein kinase 1 phosphorylates pin1 and inhibits its prolyl isomerase activity and cellular function. Mol. Cell 2011, 42:147-159.
17. Lefebvre T., Ferreira S., Dupont-Wallois L., Bussière T., Dupire M.J., Delacourte A., Michalski J.C., Caillet-Boudin M.L. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization. Biochim. Biophys. Acta 2003, 1619:167-176.
18. Leroy A., Landrieu I., Huvent I., Legrand D., Codeville B., Wieruszeski J.M., Lippens G. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J. Biol. Chem 2010, 285:33435-33444.
19. Liou Y.C., Sun A., Ryo A., Zhou X.Z., Yu Z.X., Huang H.K., Uchida T., Bronson R., Bing G., Li X., Hunter T., Lu K.P. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424:556-561.
20. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated Tau protein. Nature 1999, 399:784-788.
21. Lu P.J., Zhou X.Z., Liou Y.C., Noel J.P., Lu K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem 2002, 277:2381-2384.
22. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
23. Mischerikow N., Heck A.J. Targeted large-scale analysis of protein acetylation. Proteomics 2011, 11:571-589.
24. Nishi M., Akutsu H., Masui S., Kondo A., Nagashima Y., Kimura H., Perrem K., Shigeri Y., Toyoda M., Okayama A., Hirano H., Umezawa A., Yamamoto N., Lee S.W., Ryo A. A distinct role for pin1 in the induction and maintenance of pluripotency. J. Biol. Chem 2011, 286:11593-11603.
25. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., Wulf G., Lim J., Li S.H., Li X., Xia W., Nicholson L.K., Lu K.P. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
26. Ramakrishnan P., Dickson D.W., Davies P. Pin1 colocalization with phosphorylated Tau in Alzheimer's disease and other Tauopathies. Neurobiol. Dis 2003, 14:251-264.
27. Rudrabhatla P., Pant H.C. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration. J. Alzheimers Dis 2010, 19:389-403.
28. Schindowski K., Bretteville A., Leroy K., Bégard S., Brion J.P., Hamdane M., Buée L. Alzheimer's disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated Tau transgenic mouse without any motor deficits. Am. J. Pathol 2006, 169:599-616.
29. Sergeant N., Bombois S., Ghestem A., Drobecq H., Kostanjevecki V., Missiaen C., Wattez A., David J.P., Vanmechelen E., Sergheraert C., Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J. Neurochem 2003, 85:1581-1591.
30. Sergeant N., Wattez A., Galván-valencia M., Ghestem A., David J.P., Lemoine J., Sautiére P.E., Dachary J., Mazat J.P., Michalski J.C., Velours J., Mena-López R., Delacourte A. Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience 2003, 117:293-303.
31. Smet C., Sambo A.V., Wieruszeski J.M., Leroy A., Landrieu I., Buée L., Lippens G. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. Biochemistry 2004, 43:2032-2040.
32. Spillantini M.G., Crowther R.A., Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 1996, 92:42-48.
33. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Markesbery W.R., Zhou X.Z., Lu K.P., Butterfield D.A. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging 2006, 27:918-925.
34. Thorpe J.R., Morley S.J., Rulten S.L. Utilizing the peptidyl-prolyl cis-trans isomerase Pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to Tau in Alzheimer's diseased brain. J. Histochem. Cytochem 2001, 49:97-108.
35. Thorpe J.R., Mosaheb S., Hashemzadeh-Bonehi L., Cairns N.J., Kay J.E., Morley S.J., Rulten S.L. Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias. Neurobiol. Dis 2004, 17:237-249.
36. Van der Jeugd A., Ahmed T., Burnouf S., Belarbi K., Hamdame M., Grosjean M.E., Humez S., Balschun D., Blum D., Buée L., D'Hooge R. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem 2011, 95:296-304.
37. Vingtdeux V., Hamdane M., Gompel M., Bégard S., Drobecq H., Ghestem A., Grosjean M.E., Kostanjevecki V., Grognet P., Vanmechelen E., Buée L., Delacourte A., Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol. Dis 2005, 20:625-637.
38. Wang S., Simon B.P., Bennett D.A., Schneider J.A., Malter J.S., Wang D.S. The significance of Pin1 in the development of Alzheimer's disease. J. Alzheimers Dis 2007, 11:13-23.
39. Wintjens R., Wieruszeski J.M., Drobecq H., Rousselot-Pailley P., Buée L., Lippens G., Landrieu I. 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides. J. Biol. Chem 2001, 276:25150-25156.
40. Wulf G., Finn G., Suizu F., Lu K.P. Phosphorylation-specific prolyl isomerization: is there an underlying theme?. Nat. Cell Biol 2005, 7:435-441.
41. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Küllertz G., Stark M., Fischer G., Lu K.P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.